Haruka is a graduate of Bioengineering from McGill university in Canada. Her main research focus has been analyzing the physical and mechanical properties of the epithelial-to-mesenchymal transition during cancer metastasis.
Haruka joined CELLINK as a scientific applications specialist due to her interests in cell-substrate interactions in 3D manufactured tissues. She hopes to help develop the emerging field of bio-applications in the 3D manufacturing space, and the roles of materials in the mechanobiological aspects of cell pathology.
Recent Advancements in Research Based on 3D Bioprinting Technology – From Single Cells to Miniature Organs
Thursday, 14 November 2019 at 14:00
Add to Calendar ▼2019-11-14 14:00:002019-11-14 15:00:00Europe/LondonRecent Advancements in Research Based on 3D Bioprinting Technology – From Single Cells to Miniature OrgansMicrofluidics and Organ-on-a-Chip Asia 2019 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com
One of the biggest challenges in biological and medical research is to translate scientific discoveries from the bench to clinical applications. Recently in an effort to bridge this gap, 3D bioprinting has been used to mimic native tissues. Utilizing relevant bioinks and 3D printers, one can form cell-containing small droplets with an inkjet technique, create physiologically relevant microenvironments for cells, and even print miniature organs with more sophisticated printing methods. In this talk, I will present recent developments in biomimetic architectures from single cell systems to multi-cellular tissue structures. In particular, I will focus on microfluidic and vasculature models, organoid formations, and small organ productions to recapitulate the in vivo environment. Finally, I will discuss some of the challenges to be overcome when utilizing bioprinting-based research for clinical applications of microfluidic and organ-on-a-chip technologies.
